HCAT(Health Catalyst, Inc.) · 财务报表

HCAT(Health Catalyst, Inc.) 的财务报表:医疗保健,健康信息服务。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$241.93M$276.24M$295.94M$306.58M$311.14M
毛利润—————
营业利润−$143.65M−$140.00M−$126.90M−$69.81M−$160.85M
净利润−$153.21M−$137.40M−$118.15M−$69.50M−$177.97M
经营现金流−$23.12M−$35.27M−$33.08M$14.56M$731.00K
自由现金流−$33.57M−$37.44M−$34.32M$12.94M−$237.00K
摊薄每股收益$-3.23$-2.63$-2.09$-1.15$-2.55

Health Catalyst, Inc. HCAT